These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25001174)

  • 21. The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production.
    Scull MA; Schneider WM; Flatley BR; Hayden R; Fung C; Jones CT; van de Belt M; Penin F; Rice CM
    PLoS Pathog; 2015 Nov; 11(11):e1005297. PubMed ID: 26588073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficiency of E2-p7 processing modulates production of infectious hepatitis C virus.
    Shanmugam S; Yi M
    J Virol; 2013 Oct; 87(20):11255-66. PubMed ID: 23946462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Too little, too late?" Will inhibitors of the hepatitis C virus p7 ion channel ever be used in the clinic?
    Griffin S
    Future Med Chem; 2014; 6(17):1893-907. PubMed ID: 25495983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target.
    Khaliq S; Jahan S; Hassan S
    Liver Int; 2011 May; 31(5):606-17. PubMed ID: 21457434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of hepatitis C virus p7 ion channel function and drug sensitivity identified in vitro.
    StGelais C; Foster TL; Verow M; Atkins E; Fishwick CW; Rowlands D; Harris M; Griffin S
    J Virol; 2009 Aug; 83(16):7970-81. PubMed ID: 19493992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The p7 protein of hepatitis C virus is degraded via the proteasome-dependent pathway.
    Haqshenas G
    Virus Res; 2013 Sep; 176(1-2):211-5. PubMed ID: 23830937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins.
    Ma Y; Anantpadma M; Timpe JM; Shanmugam S; Singh SM; Lemon SM; Yi M
    J Virol; 2011 Jan; 85(1):86-97. PubMed ID: 20962101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels.
    Breitinger U; Farag NS; Ali NKM; Ahmed M; El-Azizi MA; Breitinger HG
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33709903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
    Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
    Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the inhibitory mechanism of BIT225 drug against p7 viroporin using computational study.
    Behmard E; Abdolmaleki P; Taghdir M
    Biophys Chem; 2018 Feb; 233():47-54. PubMed ID: 29169687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The p7 protein of the hepatitis C virus induces cell death differently from the influenza A virus viroporin M2.
    Aweya JJ; Mak TM; Lim SG; Tan YJ
    Virus Res; 2013 Mar; 172(1-2):24-34. PubMed ID: 23246447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pore-forming activity of pestivirus p7 in a minimal model system supports genus-specific viroporin function.
    Largo E; Gladue DP; Huarte N; Borca MV; Nieva JL
    Antiviral Res; 2014 Jan; 101():30-6. PubMed ID: 24189547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional characterization of p7 viroporin from hepatitis C virus produced in a cell-free expression system.
    Soranzo T; Cortès S; Gilde F; Kreir M; Picart C; Lenormand JL
    Protein Expr Purif; 2016 Feb; 118():83-91. PubMed ID: 26477501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitor Development against p7 Channel in Hepatitis C Virus.
    Wei S; Hu X; Du L; Zhao L; Xue H; Liu C; Chou JJ; Zhong J; Tong Y; Wang S; OuYang B
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33802584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel.
    Foster TL; Verow M; Wozniak AL; Bentham MJ; Thompson J; Atkins E; Weinman SA; Fishwick C; Foster R; Harris M; Griffin S
    Hepatology; 2011 Jul; 54(1):79-90. PubMed ID: 21520195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro.
    Hong W; Lang Y; Li T; Zeng Z; Song Y; Wu Y; Li W; Cao Z
    J Biol Chem; 2015 Sep; 290(38):23254-63. PubMed ID: 26251517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR structure and ion channel activity of the p7 protein from hepatitis C virus.
    Montserret R; Saint N; Vanbelle C; Salvay AG; Simorre JP; Ebel C; Sapay N; Renisio JG; Böckmann A; Steinmann E; Pietschmann T; Dubuisson J; Chipot C; Penin F
    J Biol Chem; 2010 Oct; 285(41):31446-61. PubMed ID: 20667830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria.
    Griffin SDC; Harvey R; Clarke DS; Barclay WS; Harris M; Rowlands DJ
    J Gen Virol; 2004 Feb; 85(Pt 2):451-461. PubMed ID: 14769903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus p7 induces mitochondrial depolarization of isolated liver mitochondria.
    You DG; Lee HR; Kim WK; Kim HJ; Lee GY; Yoo YD
    Mol Med Rep; 2017 Dec; 16(6):9533-9538. PubMed ID: 29039530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction and Analysis of Three-Dimensional Structure of the p7- Transactivated Protein1 of Hepatitis C Virus.
    El Hefnawi MM; Hasan ME; Mahmoud A; Khidr YA; El Behaidy WH; El-Absawy EA; Hemeida AA
    Infect Disord Drug Targets; 2019; 19(1):55-66. PubMed ID: 29243584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.